A recent study from the University of Southern California found that prices charged by hospitals in the Sutter Health system are about 25 percent higher than those of other hospitals in California.
Ken James/Bloomberg via Getty Images
After several prominent safety problems with medical devices in hospitals emerged, the Food and Drug Administration inspected 17 hospitals across the country in late 2015 to assess their compliance with reporting regulations.
Congressional Quarterly/CQ-Roll Call, Inc./Getty Images
Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the company's medicine for Duchenne muscular dystropy was approved Sept. 19. Now Sarepta is looking to sell the voucher to the highest bidder.
Mick Wiggins/Ikon Images/Getty Images
Mylan, the maker of EpiPen, says it will sell a generic version for $300 for a two-pack, a price that consumer advocates say is still too high. The device is used to treat severe allergic reactions.
Daniel Acker/Bloomberg via Getty Images
Careful audits of a representative sampling of bills from 37 Medicare Advantage Programs in 2007 have revealed some consistent patterns in the way they overbill, a Center for Public Integrity investigation finds.
Nick Shepherd/Ikon Images/Getty Images